Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation (Englisch)
- Neue Suche nach: Modarresi, F.
- Neue Suche nach: Faghihi, M. A.
- Neue Suche nach: Lopez-Toledano, M. A.
- Neue Suche nach: Fatemi, R. P.
- Neue Suche nach: Magistri, M.
- Neue Suche nach: Brothers, S. P.
- Neue Suche nach: van der Brug, M. P.
- Neue Suche nach: Wahlestedt, C.
- Neue Suche nach: Modarresi, F.
- Neue Suche nach: Faghihi, M. A.
- Neue Suche nach: Lopez-Toledano, M. A.
- Neue Suche nach: Fatemi, R. P.
- Neue Suche nach: Magistri, M.
- Neue Suche nach: Brothers, S. P.
- Neue Suche nach: van der Brug, M. P.
- Neue Suche nach: Wahlestedt, C.
In:
NATURE BIOTECHNOLOGY
;
30
, 5
;
453-459
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation
-
Beteiligte:Modarresi, F. ( Autor:in ) / Faghihi, M. A. ( Autor:in ) / Lopez-Toledano, M. A. ( Autor:in ) / Fatemi, R. P. ( Autor:in ) / Magistri, M. ( Autor:in ) / Brothers, S. P. ( Autor:in ) / van der Brug, M. P. ( Autor:in ) / Wahlestedt, C. ( Autor:in )
-
Erschienen in:NATURE BIOTECHNOLOGY ; 30, 5 ; 453-459
-
Verlag:
- Neue Suche nach: Nature Publishing Group
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:7 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 660.6
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 660.6 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 30, Ausgabe 5
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 371
-
Shining a light on trial data| 2012
- 372
-
Biomarkers unbound| 2012
- 373
-
Industry reels as Prometheus falls and Myriad faces further reviewsFox, Jeffrey L. et al. | 2012
- 374
-
JAK pot for GalapagosSinha, Gunjan et al. | 2012
- 375
-
Stromedix acquisition signals growing interest in fibrosisAllison, Malorye et al. | 2012
- 376
-
1000 genomes on Amazon's cloudWaltz, Emily et al. | 2012
- 377
-
Affymax poised to challenge AmgenMoran, Nuala et al. | 2012
- 378
-
UK biotech's shot in the armAldridge, Susan et al. | 2012
- 379
-
Texas legitimizes path around FDA oversightDeFrancesco, Laura et al. | 2012
- 380
-
Fifth time's the charm for infant respiratory distress drugKatsnelson, Alla et al. | 2012
- 380
-
Industry trial bias refutedRoberts, Josh P et al. | 2012
- 380
-
Blood test for Down syndromeRohn, Jennifer et al. | 2012
- 381
-
Hypoxia-activated prodrugs forge ahead in cancerKling, Jim et al. | 2012
- 382
-
Around the world in a month| 2012
- 383
-
Drug pipeline: 1Q12Mak, Craig et al. | 2012
- 384
-
Biotech equities heat up in 1Q12Yang, Walter et al. | 2012
- 385
-
Recasting natural product researchSheridan, Cormac et al. | 2012
- 388
-
A work in progressPolvino, Bill et al. | 2012
- 390
-
High-efficiency TALEN-based gene editing produces disease-resistant riceLi, Ting et al. | 2012
- 392
-
How Europe's ethical divide looms over biotech law and patentsGaskell, George et al. | 2012
- 394
-
The many faces of Bruton's tyrosine kinaseMcAtee, C Patrick et al. | 2012
- 395
-
Biotech's wellspring: a survey of the health of the private sectorHuggett, Brady et al. | 2012
- 401
-
Biotech innovation in a first-to-file worldCamacho, Jennifer A et al. | 2012
- 404
-
Recent patent applications in genomic mapping| 2012
- 405
-
Direct cloning of large genomic sequencesCobb, Ryan E et al. | 2012
- 407
-
Controlled drug release by a nanorobotFu, Jinglin et al. | 2012
- 408
-
Cancer sequencing unravels clonal evolutionCaldas, Carlos et al. | 2012
- 411
-
Docetaxel-loaded nanoparticles shrink human tumorsJones, Susan et al. | 2012
- 411
-
Drug lead for osteoarthritisMak, Craig et al. | 2012
- 411
-
Engineering a thymusDeFrancesco, Laura et al. | 2012
- 411
-
Pharmacogenomic profiling of cancer drugsAschheim, Kathy et al. | 2012
- 411
-
Zinc-finger nucleases hone tumor cell therapyKreisberg, Jason et al. | 2012
- 413
-
Absolute quantification of somatic DNA alterations in human cancerCarter, Scott L et al. | 2012
- 423
-
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case studyHaynes, Barton F et al. | 2012
- 434
-
Performance comparison of benchtop high-throughput sequencing platformsLoman, Nicholas J et al. | 2012
- 440
-
Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospectingFu, Jun et al. | 2012
- 447
-
A proteomics approach for the identification and cloning of monoclonal antibodies from serumCheung, Wan Cheung et al. | 2012
- 453
-
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulationModarresi, Farzaneh et al. | 2012
- 460
-
FLASH assembly of TALENs for high-throughput genome editingReyon, Deepak et al. | 2012
- 466
-
Fate of novel painkiller mAbs hangs in balanceGarber, Ken et al. | 2012
- 466
-
Personal medicine—the new banking crisisScott, Christopher Thomas et al. | 2012
- 466
-
Existing agbiotech traits continue global marchMarshall, Andrew et al. | 2012
- 467
-
First-quarter biotech job pictureFrancisco, Michael et al. | 2012
- 468
-
People| 2012
-
In this issue| 2012